Mastocytosis: Clinical Trials

2 trials for Mastocytosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Recruiting 1

Follow Mastocytosis: new trials by email Literature Review of Mastocytosis trials Research Report on Mastocytosis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Avapritinib Rollover Study
Avapritinib - Mastocytosis, Systemic
Phase 4RecruitingBlueprint Medicines Corporation602024-11-282026-11-12
Imatinib in KIT-negative Systemic Mastocytosis
Imatinib Mesylate - Systemic Mastocytosis
Phase 4CompletedHospital Virgen de la Salud102011-01-012016-08-29

Narrower conditions

Mastocytosis, Systemic (2)  ·  Mast Cell Activation Disorders (1)

Broader conditions

Immune System Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Connective Tissue (2)  ·  Neoplasms, Connective and Soft Tissue (2)  ·  Mast Cell Activation Disorders (1)

Interventions

Imatinib Mesylate (1)  ·  avapritinib (1)

Sponsors

Blueprint Medicines Corporation (1)  ·  Hospital Virgen de la Salud (1)

Countries

Spain (2)  ·  Belgium (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Norway (1)  ·  United Kingdom (1)

Top investigators

Luis Escribano, MD, PhD (1)

Results publications

PMID 15070706, PMID 18567837